From: Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review
Reference | Biomarker | Age (years) Mean ± SD Median (range) | Sex (% Male) | Race (% Caucasian) | Method used to obtain GFR | Baseline GFR Mean ± SD Median (range) |
---|---|---|---|---|---|---|
El Ghoul et al [14] | Urine PIIINP | 46 ± 17 | 48% | 88% | Four variable MDRD | 48.9 (3.4 - 203.1) |
Teppo et al [15] | Urine PIIINP | 47 (22-68) | 61% | NR | 24-h creatinine clearance | 56.2 |
Soylemezoglu et al [16] | Urine and blood PIIINP | 51 ± 18 | NR | NR | NR | NR |
Honkanen et al [20] | Urine TGF- β | 43a | 65% | NR | 51Cr-EDTA- clearance or 24-h creatinine clearance | NR |
Susianti et al [21] | Urine TGF- β | 30b | 7% | NR | NR | NR |
Murakami et al [22] | Urine TGF-β | NR | NR | NR | NR | NR |
Zhang et al [24] | Urine MCP-1, Hepcidin, LFABP | 30 (17-51) | 11% | 46% | NR | NR |
Chang et al [25] | Blood PAI-1 | 51a | 10% | NR | MDRD | 31.5c |
Sanders et al [26] | Urine MMP-2 Urine TIMP-1 | 67 (23-86) | NR | NR | NR | NR |
Grenzi et al [18] | Blood CD30 | 35 (4.8–67.1) | 56% | 29% | Cockgraft-gault | NR |
Amer et al [10] | Urine RBP | 52 ± 13 | 55% | 93% | Four variable MDRD Iothalamate measurement | 53.7 ± 14.9 57.5 ± 17.1 |
Barbosa de Deus et al [11] | Urine RBP | 33 ± 12 | 54% | 53% | Creatinine clearance | 73.2 (33-172)d 97.5 (45-175) |
Pallet et al [12] | Urine RBP | 53 ± 18 | 54% | 53% | MDRD | 47.4 ± 33.3 |
Zhu et al [13] | Blood VCAM-1 | 33 ± 11 | 47% | NR | NR | 85.4 ± 30.3 |
Metalidis et al [17] | Urine CTGF | 53 ± 13.2 | 61% | NR | MDRD | 53.3 ± 17.4 |
Liu et al [19] | Urine MBL | 35 | 57% | NR | Four variable MDRD | 85.9 |
Lu et al [23] | Urine SGK-1 | 38b | 52% | NR | MDRD | 90.8 ± 43.2 |